Cargando…
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso
(1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying m...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145444/ https://www.ncbi.nlm.nih.gov/pubmed/37104321 http://dx.doi.org/10.3390/tropicalmed8040195 |
_version_ | 1785034334878564352 |
---|---|
author | Kaboré, Jean Moïse Tanga Siribié, Mohamadou Hien, Denise Soulama, Issiaka Barry, Nouhoun Baguiya, Adama Tiono, Alfred B. Burri, Christian Tchouatieu, André-Marie Sirima, Sodiomon B. |
author_facet | Kaboré, Jean Moïse Tanga Siribié, Mohamadou Hien, Denise Soulama, Issiaka Barry, Nouhoun Baguiya, Adama Tiono, Alfred B. Burri, Christian Tchouatieu, André-Marie Sirima, Sodiomon B. |
author_sort | Kaboré, Jean Moïse Tanga |
collection | PubMed |
description | (1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying multiple first-line therapies (MFT) may help mitigate this threat and extend the therapeutic life of current ACTs. (2) Methods: A district-wide pilot quasi-experimental study was conducted, deploying three different ACTs at the public health facility (PHF) level for uncomplicated malaria treatment from December 2019 to December 2020 in the health district (HD) of Kaya, Burkina Faso. Mixed methods, including household and health facility-based quantitative and qualitative surveys, were used to evaluate the pilot programme. (3) Results: A total of 2008 suspected malaria patients were surveyed at PHFs, of which 79.1% were tested by rapid diagnostic test (RDT) with 65.5% positivity rate. In total, 86.1% of the confirmed cases received the appropriate ACT according to the MFT strategy. The adherence level did not differ by study segment (p = 0.19). Overall, the compliance level of health workers (HWs) with MFT strategy was 72.7% (95% CI: 69.7–75.5). The odds of using PHF as the first source of care increased after the intervention (aOR = 1.6; 95% CI, 1.3–1.9), and the reported adherence to the 3-day treatment regimen was 82.1%; (95% CI: 79.6–84.3). Qualitative results showed a high acceptance of the MFT strategy with positive opinions from all stakeholders. (4) Conclusions: Implementing an MFT strategy is operationally feasible and acceptable by stakeholders in the health systems in Burkina Faso. This study provides evidence to support the simultaneous use of multiple first-line artemisinin combination therapies in malaria-endemic countries such as Burkina Faso. |
format | Online Article Text |
id | pubmed-10145444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101454442023-04-29 Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso Kaboré, Jean Moïse Tanga Siribié, Mohamadou Hien, Denise Soulama, Issiaka Barry, Nouhoun Baguiya, Adama Tiono, Alfred B. Burri, Christian Tchouatieu, André-Marie Sirima, Sodiomon B. Trop Med Infect Dis Article (1) Background: Effective malaria case management relies on World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs), but partial resistance to artemisinin has emerged and is spreading, threatening malaria control and elimination efforts. The strategy of deploying multiple first-line therapies (MFT) may help mitigate this threat and extend the therapeutic life of current ACTs. (2) Methods: A district-wide pilot quasi-experimental study was conducted, deploying three different ACTs at the public health facility (PHF) level for uncomplicated malaria treatment from December 2019 to December 2020 in the health district (HD) of Kaya, Burkina Faso. Mixed methods, including household and health facility-based quantitative and qualitative surveys, were used to evaluate the pilot programme. (3) Results: A total of 2008 suspected malaria patients were surveyed at PHFs, of which 79.1% were tested by rapid diagnostic test (RDT) with 65.5% positivity rate. In total, 86.1% of the confirmed cases received the appropriate ACT according to the MFT strategy. The adherence level did not differ by study segment (p = 0.19). Overall, the compliance level of health workers (HWs) with MFT strategy was 72.7% (95% CI: 69.7–75.5). The odds of using PHF as the first source of care increased after the intervention (aOR = 1.6; 95% CI, 1.3–1.9), and the reported adherence to the 3-day treatment regimen was 82.1%; (95% CI: 79.6–84.3). Qualitative results showed a high acceptance of the MFT strategy with positive opinions from all stakeholders. (4) Conclusions: Implementing an MFT strategy is operationally feasible and acceptable by stakeholders in the health systems in Burkina Faso. This study provides evidence to support the simultaneous use of multiple first-line artemisinin combination therapies in malaria-endemic countries such as Burkina Faso. MDPI 2023-03-28 /pmc/articles/PMC10145444/ /pubmed/37104321 http://dx.doi.org/10.3390/tropicalmed8040195 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kaboré, Jean Moïse Tanga Siribié, Mohamadou Hien, Denise Soulama, Issiaka Barry, Nouhoun Baguiya, Adama Tiono, Alfred B. Burri, Christian Tchouatieu, André-Marie Sirima, Sodiomon B. Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title | Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title_full | Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title_fullStr | Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title_full_unstemmed | Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title_short | Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso |
title_sort | feasibility and acceptability of a strategy deploying multiple first-line artemisinin-based combination therapies for uncomplicated malaria in the health district of kaya, burkina faso |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145444/ https://www.ncbi.nlm.nih.gov/pubmed/37104321 http://dx.doi.org/10.3390/tropicalmed8040195 |
work_keys_str_mv | AT kaborejeanmoisetanga feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT siribiemohamadou feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT hiendenise feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT soulamaissiaka feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT barrynouhoun feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT baguiyaadama feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT tionoalfredb feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT burrichristian feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT tchouatieuandremarie feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso AT sirimasodiomonb feasibilityandacceptabilityofastrategydeployingmultiplefirstlineartemisininbasedcombinationtherapiesforuncomplicatedmalariainthehealthdistrictofkayaburkinafaso |